Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Endogenous peptide hormone inolved in gastric e...
A bacteriocin
Endogenous peptide hormone inolved in gastric e...
Aromatase inhibitor.
Reversible DNMT1-selective inhibitor
Aurora kinase A inhibitor.
Vitamin B1
Inhibitor of PI3K.
AR antagonist.
Endogenous bombesin-like peptide, involved in f...
PKC and PKD activator, carcinogen.
Multikinase inhibitor.
Endogenous neuropeptide hormone; somatostatin a...
Carnitine derivative, involved in energy homeos...
α1-adrenergic agonist.
PI3K and HDAC inhibitor.
AhR agonist, dihydroorotate dehydrogenase inhib...
Endogenous component of sphingolipids; PKC inhi...
Synthetic taxol synthesis intermediate; microtu...
Phenol found in Zingiber; PPARγ agonist, 5-HT3...